Advanced gene editing ‘promising’ for sickle cell disease, but access challenges remain

Summary: Sickle cell disease causes severe pain and organ damage, mostly affecting Black Americans. New gene-editing treatments are acting like a "functional cure" by fixing a patient's DNA to produce healthy red blood cells. In two recent studies, patients had almost zero pain crises after treatment! However, these amazing treatments are incredibly expensive and hard to make. Doctors are now pushing for better, cheaper ways to make sure everyone who needs this life-saving cure can actually get it.

For more details, see Healio at healio.com/news/hematology-oncology/20260427/advanced-gene-editing-promising-for-sickle-cell-disease-but-access-challenges-remain (opens in new tab)

Tags

Hematology
Anemia, Sickle Cell
Graft vs Host Disease
Anemia, Hemolytic
Death
Disease
Anemia
Stem Cell Transplantation
Bone Marrow Transplantation
Hematopoietic Stem Cells
Hematopoietic Stem Cell Transplantation